78 related articles for article (PubMed ID: 18548616)
1. Determining degree of saturation after application of transiently supersaturated metered dose aerosols for topical delivery of corticosteroids.
Jones SA; Reid ML; Brown MB
J Pharm Sci; 2009 Feb; 98(2):543-54. PubMed ID: 18548616
[TBL] [Abstract][Full Text] [Related]
2. Transient drug supersaturation kinetics of beclomethasone dipropionate in rapidly drying films.
Reid ML; Jones SA; Brown MB
Int J Pharm; 2009 Apr; 371(1-2):114-9. PubMed ID: 19150492
[TBL] [Abstract][Full Text] [Related]
3. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays.
Reid ML; Benaouda F; Khengar R; Jones SA; Brown MB
Int J Pharm; 2013 Aug; 452(1-2):157-65. PubMed ID: 23684656
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent.
Reid ML; Brown MB; Jones SA
Pharm Res; 2008 Nov; 25(11):2573-80. PubMed ID: 18668352
[TBL] [Abstract][Full Text] [Related]
5. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
6. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
7. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.
Jones SA; Martin GP; Brown MB
J Pharm Sci; 2006 May; 95(5):1060-74. PubMed ID: 16552748
[TBL] [Abstract][Full Text] [Related]
9. An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes.
Reid ML; Brown MB; Moss GP; Jones SA
J Pharm Pharmacol; 2008 Sep; 60(9):1139-47. PubMed ID: 18718116
[TBL] [Abstract][Full Text] [Related]
10. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
Gupta A; Stein SW; Myrdal PB
J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
[TBL] [Abstract][Full Text] [Related]
11. Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro.
Haghi M; Bebawy M; Colombo P; Forbes B; Lewis DA; Salama R; Traini D; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):38-45. PubMed ID: 23528797
[TBL] [Abstract][Full Text] [Related]
12. Enhanced permeation of fentanyl from supersaturated solutions in a model membrane.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2011 Apr; 407(1-2):72-7. PubMed ID: 21256946
[TBL] [Abstract][Full Text] [Related]
13. The effect of drug concentration on solvent activity in silicone membranes.
Santos P; Machado M; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2009 Jul; 377(1-2):70-5. PubMed ID: 19439167
[TBL] [Abstract][Full Text] [Related]
14. The influence of volatile solvents on transport across model membranes and human skin.
Oliveira G; Hadgraft J; Lane ME
Int J Pharm; 2012 Oct; 435(1):38-49. PubMed ID: 22634140
[TBL] [Abstract][Full Text] [Related]
15. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin.
Frederiksen K; Guy RH; Petersson K
Eur J Pharm Biopharm; 2015 Apr; 91():9-15. PubMed ID: 25595740
[TBL] [Abstract][Full Text] [Related]
16. Effect of facial material softness and applied force on face mask dead volume, face mask seal, and inhaled corticosteroid delivery through an idealized infant replica.
Carrigy NB; O'Reilly C; Schmitt J; Noga M; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):290-8. PubMed ID: 24219815
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
18. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
19. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations.
Eroğlu İ; Azizoğlu E; Özyazıcı M; Nenni M; Gürer Orhan H; Özbal S; Tekmen I; Ertam İ; Ünal İ; Özer Ö
Drug Deliv; 2016 Jun; 23(5):1502-13. PubMed ID: 25259424
[TBL] [Abstract][Full Text] [Related]
20. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
